Jefferies Initiates Coverage On Pacific Biosciences with Buy Rating, Announces Price Target of $4
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Tycho Peterson has initiated coverage on Pacific Biosciences (NASDAQ:PACB) with a Buy rating and set a price target of $4.
June 03, 2024 | 6:23 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Tycho Peterson has initiated coverage on Pacific Biosciences with a Buy rating and set a price target of $4.
The initiation of coverage with a Buy rating and a specific price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100